NIA Impact Advisors’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-9,289
Closed -$617K 95
2025
Q4
$617K Sell
9,289
-221
-2% -$14.3K 0.21% 71
2025
Q3
$640K Sell
9,510
-60
-0.6% -$4.75K 0.21% 71
2025
Q2
$835K Hold
9,570
0.29% 67
2025
Q1
$654K Sell
9,570
-280
-3% -$22.8K 0.24% 74
2024
Q4
$766K Buy
9,850
+140
+1% +$10.4K 0.25% 75
2024
Q3
$651K Sell
9,710
-1,920
-17% -$158K 0.22% 74
2024
Q2
$1.32M Buy
11,630
+500
+4% +$63.2K 0.47% 62
2024
Q1
$1.54M Buy
+11,130
New +$1.4M 0.62% 56

Other funds holding DXCM

NIA Impact Advisors's DXCM Position: Q1 2026 in Review

NIA Impact Advisors sold out of DexCom (DXCM) in Q1 2026, closing a stake of 9,289 shares — an estimated $617K sold.

NIA Impact Advisors first reported a position in DXCM in Q1 2024 and held it in 8 quarters. The position peaked at $1.54M in Q1 2024. 960 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • NIA Impact Advisors reported no remaining DexCom position as of Q1 2026 after selling out during the quarter.
  • NIA Impact Advisors sold 9,289 DexCom shares in Q1 2026, an estimated $617K.
  • NIA Impact Advisors first reported a position in DexCom in Q1 2024 and held it in 8 quarters.
  • NIA Impact Advisors's DexCom position peaked at $1.54M in Q1 2024.
  • 960 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on NIA Impact Advisors's 13F filing for Q1 2026, filed 8 May 2026.